201 HI - Disease & Pharmacology Flashcards
Immuno- suppressors, immuno-modulators and antibody treatments
Induction therapy for transplantation
- Lymphocyte-depleting agents - Antithymocyte globulin
- Interleukin 2 receptor antagonists - Basiliximab
Glucocorticoids (corticosteroids)
Antiproliferative immunosuppressants - Azathioprine
Calcineurin inhibitors - Ciclosporin
mTOR inhibitors - Sirolimus
TNF-α inhibitors - Infliximab
Antibodies against CD20 - Rituximab
Interleukin inhibitors - Tocilizumab
Janus kinase (JAK) Inhibitors - Tofacitinib Immunomodulation therapy - Interferons, interleukins, IVIG
AE of Glucocorticoids (corticosteroids)
Immuno- suppressors, immuno-modulators and antibody treatments
Iatrogenic Cushing syndrome
Antiproliferative immunosuppressants
Immuno- suppressors, immuno-modulators and antibody treatments
Azathioprine
- Activated to 6-mercaptopurine (6-MP)
AE: Bone marrow suppression
Calcineurin inhibitors
Immuno- suppressors, immuno-modulators and antibody treatments
Ciclosporin
- Inhibit calcineurin, which normally activates the transcription of interleukin-2
AE: Hyperlipidaemia, hypertension, gingival hyperplasia, renal dysfunction
mTOR inhibitors
Immuno- suppressors, immuno-modulators and antibody treatments
Sirolimus
AE: Myelosuppression
TNF-α inhibitors
Immuno- suppressors, immuno-modulators and antibody treatments
Infliximab
AE: Latent TB and other serious infections may recur
Antithrombotic drugs
Thrombolytics/fibrinolytics - Alteplase
Heparin - Enoxaparin
Low-molecular-weight heparin - Fondaparinux
Direct thrombin inhibitor - Bivalirudin
Vitamin K antagonist - Warfarin
Direct Oral Anticoagulants (DOACs) - Dabigatran
Antiplatelet drugs:
- Aspirin
- P2Y12 antagonists - Clopidogrel (CYP2C19)
- GPIIb/IIIa Receptor Antagonists - Abciximab
Thrombolytics/fibrinolytics
Antithrombotic drugs
Alteplase
- Enzymically activate plasminogen to give plasmin which digests fibrin and fibrinogen, lysing the clot.
AE: Bleeding
Heparin, low-molecular-weight heparin
Antithrombotic drugs
Enoxaparin
- Binds to AT III → inhibits factor Xa
Vitamin K antagonist
Antithrombotic drugs
Warfarin
- Inhibits the reduction of vitamin K and thus prevents the γ-carboxylation of the glutamate residues in factors II, VII, IX, and X
AE of Direct Oral Anticoagulants (DOACs)
Antithrombotic drugs
Bleeding
Haem iron vs non-haem iron
Haem:
- binds to haemoglobin & myoglobin
- can be found in animal products
- in ferrous state (Fe2+)
Non-Haem:
- free iron molecules
- can be found in plant-based foods
- in ferric state (Fe3+)
Mechanisms of iron absorption
- Duodenal cytochrome B reduces Fe3+ → Fe2+ (meat product not needed to be converted)
- DMT1 transport Fe2+ into duodenal enterocyte
- Ferroportin export iron from enterocyte when needed - Fe2+ released from ferritin stores into blood
- Hephaestin converts Fe2+ → Fe3+ - binds to transferrin and transported to target tissues
- Fe3+ stored in ferritin
Where does iron absorption mainly occur?
Duodenum
How is iron absorption regulated?
Hepcidin
- produced in the liver in response to increased iron load & inflammation
- binds to ferroportin and causes degradation
High hepcidin levels block intestinal iron absorption
4 main causes of iron deficiency anemia
↓ iron intake
↓ iron absorption
↑ demand
↑ loss
Hepcidin levels ______ in iron deficiency
decrease
Primary & secondary causes of iron overload
Primary:
- hereditary hemochromatosis
- iron poisoning
Secondary:
- blood transfusions
- iron loading anemias